Published 15 September 2003. doi:10.1084/jem.20030299
© Rockefeller University Press,
0022-1007/2003/9/877 $5.00
The Journal of Experimental Medicine, Volume 198, Number 6, 877-888
IL-1 Plays an Important Role in Lipid Metabolism by Regulating Insulin Levels under Physiological Conditions
Taizo Matsuki,
Reiko Horai,
Katsuko Sudo and
Yoichiro Iwakura
Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan
Address correspondence to Yoichiro Iwakura, Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Phone: 81-3-5449-5536; Fax: 81-3-5449-5430; email: iwakura{at}ims.u-tokyo.ac.jp
IL-1 is a proinflammatory cytokine that plays important roles in inflammation. However, the role of this cytokine under physiological conditions is not known completely. In this paper, we analyzed the role of IL-1 in maintaining body weight because IL-1 receptor antagonistdeficient (IL-1Ra-/-) mice, in which excess IL-1 signaling may be induced, show a lean phenotype. Body fat accumulation was impaired in IL-1Ra-/- mice, but feeding behavior, expression of hypothalamic factors involved in feeding control, energy expenditure, and heat production were normal. When IL-1Ra-/- mice were treated with monosodium glutamate (MSG), which causes obesity in wild-type mice by ablating cells in the hypothalamic arcuate nucleus, they were resistant to obesity, indicating that excess IL-1 signaling antagonizes the effect of MSG-sensitive neuron deficiency. IL-1Ra-/- mice showed decreased weight gain when they were fed the same amount of food as wild-type mice, and lipid accumulation remained impaired even when they were fed a high-fat diet. Interestingly, serum insulin levels and lipase activity were low in IL-1Ra-/- mice, and the insulin levels were low in contrast to wild-type mice after MSG treatment. These observations suggest that IL-1 plays an important role in lipid metabolism by regulating insulin levels and lipase activity under physiological conditions.
Key Words: IL-1deficient mouse IL-1 receptor antagonistdeficient mouse obese skinny model energy homeostasis

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Donath, M. Y., Storling, J., Berchtold, L. A., Billestrup, N., Mandrup-Poulsen, T.
(2008). Cytokines and {beta}-Cell Biology: from Concept to Clinical Translation. Endocr. Rev.
29: 334-350
[Abstract]
[Full Text]
-
Hausman, G. J., Barb, C. R., Dean, R. G.
(2007). Patterns of gene expression in pig adipose tissue: Transforming growth factors, interferons, interleukins, and apolipoproteins. J ANIM SCI
85: 2445-2456
[Abstract]
[Full Text]
-
Dong, X. F., Gao, W. W., Tong, J. M., Jia, H. Q., Sa, R. N., Zhang, Q.
(2007). Effect of Polysavone (Alfalfa Extract) on Abdominal Fat Deposition and Immunity in Broiler Chickens. Poult. Sci.
86: 1955-1959
[Abstract]
[Full Text]
-
Venteclef, N., Delerive, P.
(2007). Interleukin-1 Receptor Antagonist Induction as an Additional Mechanism for Liver Receptor Homolog-1 to Negatively Regulate the Hepatic Acute Phase Response. J. Biol. Chem.
282: 4393-4399
[Abstract]
[Full Text]
-
del Rey, A., Roggero, E., Randolf, A., Mahuad, C., McCann, S., Rettori, V., Besedovsky, H. O.
(2006). IL-1 resets glucose homeostasis at central levels. Proc. Natl. Acad. Sci. USA
103: 16039-16044
[Abstract]
[Full Text]
-
Strandberg, L., Lorentzon, M., Hellqvist, A., Nilsson, S., Wallenius, V., Ohlsson, C., Jansson, J.-O.
(2006). Interleukin-1 System Gene Polymorphisms Are Associated with Fat Mass in Young Men. J. Clin. Endocrinol. Metab.
91: 2749-2754
[Abstract]
[Full Text]
-
Garcia, M. C., Wernstedt, I., Berndtsson, A., Enge, M., Bell, M., Hultgren, O., Horn, M., Ahren, B., Enerback, S., Ohlsson, C., Wallenius, V., Jansson, J.-O.
(2006). Mature-onset obesity in interleukin-1 receptor I knockout mice.. Diabetes
55: 1205-1213
[Abstract]
[Full Text]
-
Chida, D., Osaka, T., Hashimoto, O., Iwakura, Y.
(2006). Combined interleukin-6 and interleukin-1 deficiency causes obesity in young mice.. Diabetes
55: 971-977
[Abstract]
[Full Text]
-
Somm, E., Henrichot, E., Pernin, A., Juge-Aubry, C. E., Muzzin, P., Dayer, J.-M., Nicklin, M. J.H., Meier, C. A.
(2005). Decreased Fat Mass in Interleukin-1 Receptor Antagonist-Deficient Mice: Impact on Adipogenesis, Food Intake, and Energy Expenditure. Diabetes
54: 3503-3509
[Abstract]
[Full Text]
-
Isoda, K., Sawada, S., Ayaori, M., Matsuki, T., Horai, R., Kagata, Y., Miyazaki, K., Kusuhara, M., Okazaki, M., Matsubara, O., Iwakura, Y., Ohsuzu, F.
(2005). Deficiency of Interleukin-1 Receptor Antagonist Deteriorates Fatty Liver and Cholesterol Metabolism in Hypercholesterolemic Mice. J. Biol. Chem.
280: 7002-7009
[Abstract]
[Full Text]
-
Bullen, J. W. Jr, Ziotopoulou, M., Ungsunan, L., Misra, J., Alevizos, I., Kokkotou, E., Maratos-Flier, E., Stephanopoulos, G., Mantzoros, C. S.
(2004). Short-term resistance to diet-induced obesity in A/J mice is not associated with regulation of hypothalamic neuropeptides. Am. J. Physiol. Endocrinol. Metab.
287: E662-E670
[Abstract]
[Full Text]
-
Juge-Aubry, C. E., Somm, E., Chicheportiche, R., Burger, D., Pernin, A., Cuenod-Pittet, B., Quinodoz, P., Giusti, V., Dayer, J.-M., Meier, C. A.
(2004). Regulatory Effects of Interleukin (IL)-1, Interferon-{beta}, and IL-4 on the Production of IL-1 Receptor Antagonist by Human Adipose Tissue. J. Clin. Endocrinol. Metab.
89: 2652-2658
[Abstract]
[Full Text]
-
Isoda, K., Sawada, S., Ishigami, N., Matsuki, T., Miyazaki, K., Kusuhara, M., Iwakura, Y., Ohsuzu, F.
(2004). Lack of Interleukin-1 Receptor Antagonist Modulates Plaque Composition in Apolipoprotein E-Deficient Mice. Arterioscler. Thromb. Vasc. Bio.
24: 1068-1073
[Abstract]
[Full Text]